KL

Karen LaRochelle

Company Strategist and Collaborations Lead, Venture Partner and Board Director

Princeton, New Jersey

Invests in

Stages:

  • Min Investment:

    $25,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,000,000.00

Work Experience

2020

  • Board Member

    2020

    Audit and Compensation Committee member

  • Consulting Chief Business Officer to multiple biotechs

    2013

    Fractional consulting CBO focused on strategy, Business Development and financing.

  • Operational Partner

    2020 - 2023

2020 - 2021

  • SVP, Corporate and Business Development

    2020 - 2021

2016 - 2019

  • Chief Business Officer

    2016 - 2019

  • Biotech Business Development

    2013 - 2016

    Collaboration consultant for biotechnology companies in the US and China. Business Development services to clients interested in out-licensing, strategic collaborations, M&A and in-licensing. Services include partnering strategy, search and evaluation, term sheet development and agreement negotiation. Transactions executed for Exelixis, Ovid Therapeutics, Chase Pharmaceuticals, Otsuka and Yabao Pharmaceuticals

1993 - 2013

  • Global Business Development & Head of China Business Development

    1993 - 2013

    Executive Director, Business Development 2006-2013 Head of China Business Development 2010-2013 Director, Business Development 2000-2006 Associate Director, International Finance 1999-2000 Manager, Business Analysis 1995-1999 Financial Associate (MBA rotational program) 1993-1995

  • Consultant

    1988 - 1991